Biotech

All Articles

Praxis epilepsy drug decreases seizures in stage 2 trial

.Praxis Accuracy Medicines has actually racked up an additional midphase win in epilepsy this year, ...

Three officers surrender as Dyne blog posts blended records for DMD applicant

.After getting away a professional hold a number of years back, Dyne Therapy has disclosed brand new...

Arrowhead fires off period 3 records in unusual metabolic health condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own hand in advance of a prospective showdown along with Io...

Pfizer, Valneva show lyme condition try helpful for second booster

.Pfizer and also Valneva might possess concerning two more years to hang around before they help mak...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a conversation along with Ayla Ellison, Intense Biotech Managing Editor as well a...

New information show how Bayer's asundexian fell short to avoid strokes

.Bayer put on hold the period 3 trial for its element XIa inhibitor asundexian late in 2014 after th...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, exe...

Galapagos' stockpile as fund presents intent to form its own development

.Galapagos is happening under added pressure from clients. Having actually constructed a 9.9% risk i...

Cell- concentrated Sana gathers 1st CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings...

Allist settles Jacobio $21M, landing role in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has acquired on its own a starring character in China's KRAS market...